VISUDYNE® therapy is approved to stop leaking from blood vessels in eyes that is caused by AMD (a condition affecting the macula of the eye which can impair vision).
Wet AMD is a serious eye disease that, if left untreated, can quickly cause severe vision loss. VISUDYNE® is a drug therapy that can slow the progression of wet AMD and may help you maintain your vision. Be sure to follow all of your doctor’s instructions, as well as all recommended safety precautions.
VISUDYNE®, also known as verteporfin for injection, is a light-activated, or photodynamic, drug. It is administered through an infusion into the patient’s arm to travel through the bloodstream. The drug then circulates throughout the body; the abnormal vessels in the patient’s eye attract and absorb the drug.
It is then activated by a low-energy laser, which produces a reaction that damages and closes abnormal vessels
Multiple courses of therapy are often necessary because the abnormal blood vessels may not be fully closed off and leakage may recur. Despite the need for multiple treatments, stoppage of leakage and stability of visual function are achieved in many patients
Individual results may vary. VISUDYNE® therapy may be repeated at 3-month intervals if necessary.
VISUDYNE® (verteporfin for injection) is used along with laser light treatment to stop leaking from blood vessels in the eye due to the following serious eye conditions: age-related macular degeneration (a condition affecting the retina of the eye which can impair vision), pathologic myopia (extreme nearsightedness) or ocular histoplasmosis (a certain type of fungus infection in the eye).
You are encouraged to report side effects to the FDA. To report SUSPECTED ADVERSE REACTIONS, contact Bausch + Lomb, a division of Valeant Pharmaceuticals North America LLC, at 1‑800‑321‑4576 or FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch.
Please click here for full Prescribing Information for VISUDYNE®.
Indication and Important Safety Information
VISUDYNE is a registered trademark of Novartis AG used under license. ©Bausch & Lomb Incorporated. VID.0046.USA.17